Literature DB >> 26781304

Creatine supplementation prevents hyperhomocysteinemia, oxidative stress and cancer-induced cachexia progression in Walker-256 tumor-bearing rats.

Rafael Deminice1, Paola Sanches Cella2, Camila S Padilha2, Fernando H Borges3, Lilian Eslaine Costa Mendes da Silva4, Patrícia L Campos-Ferraz5, Alceu Afonso Jordao4, Jason Lorne Robinson6, Robert F Bertolo6, Rubens Cecchini3, Flávia Alessandra Guarnier3.   

Abstract

The purpose of this study was to investigate (1) the impact of tumor growth on homocysteine (Hcy) metabolism, liver oxidative stress and cancer cachexia and, (2) the potential benefits of creatine supplementation in Walker-256 tumor-bearing rats. Three experiments were conducted. First, rats were killed on days 5 (D5), 10 (D10) and 14 (D14) after tumor implantation. In experiment 2, rats were randomly assigned to three groups designated as control (C), tumor-bearing (T) and tumor-bearing supplemented with creatine (TCr). A life span experiment was conducted as the third experiment. Creatine was supplied in drinking water for 21 days (8 g/L) in all cases. Tumor implantation consisted of a suspension of Walker-256 cells (8.0 × 10(7) cells in 0.5 mL of PBS). The progressive increase (P < 0.05) in tumor mass coincided with a progressively lower body weight and higher hepatic oxidative stress; plasma Hcy concentration was 80 % higher (P < 0.05) by 10 days of tumor implantation. Impaired Hcy metabolism was evidenced by decreased hepatic betaine-homocysteine methyltransferase (Bhmt), glycine N-methyltransferase (Gnmt) and cystathionine beta synthase (CBS) gene expression. In contrast, creatine supplementation promoted a 28 % reduction of tumor weight (P < 0.05). Plasma Hcy (C 6.1 ± 0.6, T 10.3 ± 1.5, TCr 6.3 ± 0.9, µmol/L) and hepatic oxidative stress were lower in the TCr group compared to T. Creatine supplementation was unable to decrease Hcy concentration and to increase SAM/SAH ratio in tumor tissue. These data suggest that creatine effects on hepatic impaired Hcy metabolism promoted by tumor cell inoculation are responsible to decrease plasma Hcy in tumor-bearing rats. In conclusion, Walker-256 tumor growth is associated with progressive hyperhomocysteinemia, body weight loss and liver oxidative stress in rats. Creatine supplementation, however, prevented these tumor-associated perturbations.

Entities:  

Keywords:  Cancer; Creatine; Homocysteine; Oxidative stress; Rats

Mesh:

Substances:

Year:  2016        PMID: 26781304     DOI: 10.1007/s00726-016-2172-9

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  11 in total

1.  Creatine supplementation in Walker-256 tumor-bearing rats prevents skeletal muscle atrophy by attenuating systemic inflammation and protein degradation signaling.

Authors:  Paola S Cella; Poliana C Marinello; Fernando H Borges; Diogo F Ribeiro; Patrícia Chimin; Mayra T J Testa; Philippe B Guirro; José A Duarte; Rubens Cecchini; Flávia A Guarnier; Rafael Deminice
Journal:  Eur J Nutr       Date:  2019-02-26       Impact factor: 5.614

Review 2.  Muscle alterations in the development and progression of cancer-induced muscle atrophy: a review.

Authors:  Megan E Rosa-Caldwell; Dennis K Fix; Tyrone A Washington; Nicholas P Greene
Journal:  J Appl Physiol (1985)       Date:  2019-11-14

3.  An AMP-activated protein kinase-stabilizing peptide ameliorates adipose tissue wasting in cancer cachexia in mice.

Authors:  Maria Rohm; Michaela Schäfer; Victor Laurent; Bilgen Ekim Üstünel; Katharina Niopek; Carolyn Algire; Oksana Hautzinger; Tjeerd P Sijmonsma; Annika Zota; Dasa Medrikova; Natalia S Pellegata; Mikael Ryden; Agné Kulyte; Ingrid Dahlman; Peter Arner; Natasa Petrovic; Barbara Cannon; Ez-Zoubir Amri; Bruce E Kemp; Gregory R Steinberg; Petra Janovska; Jan Kopecky; Christian Wolfrum; Matthias Blüher; Mauricio Berriel Diaz; Stephan Herzig
Journal:  Nat Med       Date:  2016-08-29       Impact factor: 53.440

Review 4.  International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine.

Authors:  Richard B Kreider; Douglas S Kalman; Jose Antonio; Tim N Ziegenfuss; Robert Wildman; Rick Collins; Darren G Candow; Susan M Kleiner; Anthony L Almada; Hector L Lopez
Journal:  J Int Soc Sports Nutr       Date:  2017-06-13       Impact factor: 5.150

Review 5.  The Walker 256 Breast Cancer Cell- Induced Bone Pain Model in Rats.

Authors:  Priyank A Shenoy; Andy Kuo; Irina Vetter; Maree T Smith
Journal:  Front Pharmacol       Date:  2016-08-31       Impact factor: 5.810

Review 6.  The Evolving Applications of Creatine Supplementation: Could Creatine Improve Vascular Health?

Authors:  Holly Clarke; Do-Houn Kim; Cesar A Meza; Michael J Ormsbee; Robert C Hickner
Journal:  Nutrients       Date:  2020-09-16       Impact factor: 5.717

Review 7.  Nutritional Interventions in Cancer Cachexia: Evidence and Perspectives From Experimental Models.

Authors:  Wouter R P H van de Worp; Annemie M W J Schols; Jan Theys; Ardy van Helvoort; Ramon C J Langen
Journal:  Front Nutr       Date:  2020-12-22

8.  Creatine in Health and Disease.

Authors:  Richard B Kreider; Jeffery R Stout
Journal:  Nutrients       Date:  2021-01-29       Impact factor: 5.717

Review 9.  A Hypothesis From Metabolomics Analysis of Diabetic Retinopathy: Arginine-Creatine Metabolic Pathway May Be a New Treatment Strategy for Diabetic Retinopathy.

Authors:  Ye Sun; Ling Kong; Ai-Hua Zhang; Ying Han; Hui Sun; Guang-Li Yan; Xi-Jun Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-24       Impact factor: 5.555

10.  San-Huang-Yi-Shen Capsule Ameliorates Diabetic Nephropathy in Rats Through Modulating the Gut Microbiota and Overall Metabolism.

Authors:  Xiuhai Su; Wenxia Yu; Airu Liu; Congxiang Wang; Xiuzhen Li; Juanjuan Gao; Xiaofei Liu; Wenhui Jiang; Yue Yang; Shuquan Lv
Journal:  Front Pharmacol       Date:  2022-01-04       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.